Effects of a Protocol Combining a Non-Irritating Shampoo and an Adelmidrol-Based Adsorbent Mousse on Seborrhoea and Other Signs and Symptoms Secondary to Canine Atopic Dermatitis: A Multicenter, Open-Label Uncontrolled Clinical Trial

The present study aimed at evaluating the effect of a gentle shampoo and a mousse containing Adelmidrol, tapioca starch and a non-prescription antimicrobial complex on seborrhoea and other clinical signs secondary to canine atopic dermatitis (cAD). Forty-six dogs with cAD-associated seborrhoea and/or pruritus > 4 cm on the pruritus visual analogue scale (P-VAS) and/or bacterial/Malassezia overgrowth were enrolled. The mousse was applied twice daily, and dogs were evaluated at days (D)0, 7, 14 and optionally 28, by means of a skin seborrheic index (SSI), P-VAS, cAD lesion index (CADLI), and a semiquantitative cytological score. The mean SSI value improved during the first two weeks (4.1 +/- 0.37 to 1.9 +/- 0.30; p < 0.0001). The mean P-VAS score (cm) decreased from 6.6 +/- 0.19 at D0 to 3.8 +/- 0.31 at D14 (p < 0.0001). The mean CADLI score dropped from 13.7 +/- 1.24 to 8.5 +/- 1.14 at D14 (p < 0.001). The cytological score for bacteria and Malassezia decreased from 3.2 +/- 0.10 and 3.2 +/- 0.11, respectively, to 1.2 +/- 0.19 and 1.2 +/- 0.24 (p < 0.0001). All the investigated signs further improved at D28. Altogether, these observations suggest that the tested protocol might be useful in managing cAD-associated signs.